CTRI/2012/09/002947已完成4 期
Comparative evaluation of efficacy and safety profile of Rhubarb and alpha-Keto analogue of amino acid supplementation on patients of Chronic Kidney Disease.
Department Of Pharmacology And Department Of Medicine0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Chronic kidney disease of different etiology, before ESRD.
- •Patient not on dialysis.
排除标准
- •Acute infection
- •Psychotic patient
- •Critically ill patient
- •HIV/HBsAg/Anti-HCV and immunocompromised patient.
- •Severe Renal pathology such as malignancy
研究者
相似试验
招募中
4 期
Study to compare which iron preparations is better for treatment of anaemic in patients of chronic kidney disease.CTRI/2017/08/009343Jawaharlal Nehru Medical College Hospital
招募中
4 期
To know the safety and efficacy of Antioxidants in Patients of chronic obstructive pulmonary disease.CTRI/2015/01/005432Jawaharlal Nehru Medical College and Hospital Aligarh Muslim University Aligarh150
进行中（未招募）
不适用
Dexmedetomedine intravenous sedation on patients with and without Beta blockersCTRI/2018/08/015387ETHRADHAMA SUPER SPECIALITY EYE HOSPITA
招募中
3 期
Comparative assessment of the efficacy and safety of add ontreatment with Sofosbuvir standard of care therapeutic regimenVelpatasvir” to standard of caretherapeutic regimen” in patients with COVID-19COVID-19.COVID-19 diseaseU07.1IRCT20130812014333N145Kermanshah University of Medical Sciences80
招募中
3 期
Comparative assessment of the efficacy and safety of addon treatment with Sofosbuvir-Daclatasvir”, Lithium”,and Trifluoprazine” to standard of care in three groups of patients with COVID-19IRCT20130812014333N147Kermanshah University of Medical Sciences80